Literature DB >> 8904894

Is apoptosis a massive process in myelodysplastic syndromes?

P Lepelley1, L Campergue, N Grardel, C Preudhomme, A Cosson, P Fenaux.   

Abstract

We looked for increased apoptosis in fresh bone marrow aspirates in 40 cases of myelodysplastic syndrome (MDS), by detection of DNA fragmentation using TdT incorporation of nucleotides on 3' ends of DNA (TUNEL technique). No DNA laddering was seen. In six cases (15%) the TUNEL technique showed a moderate increase in the percentage of apoptotic cells (2.5-5% in comparison with < 2% in controls). In seven of the 34 patients with normal findings by TUNEL analysis, apoptosis was reanalysed after short-term (18 h) bone marrow culture without inducers of apoptosis. Increased apoptosis was shown in four of the seven cases by morphological analysis and/or the TUNEL technique. Increased apoptosis predominated on erythroblasts in three of them. The percentage of apoptotic cells, however, was < 40% in all samples. Our findings suggest that increased apoptosis can be detected in one half of MDS cases after cell culture. Furthermore, the precise relationship between increased apoptosis of myeloid precursors and cytopenias will have to be more precisely explored in MDS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8904894     DOI: 10.1046/j.1365-2141.1996.d01-1915.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

Review 1.  Myelodysplasia and apoptosis: new insights into ineffective erythropoiesis.

Authors:  A A van de Loosdrecht; E Vellenga
Journal:  Med Oncol       Date:  2000-02       Impact factor: 3.064

Review 2.  The role of apoptosis in the pathogenesis of the myelodysplastic syndromes.

Authors:  Jane E Parker; Ghulam J Mufti
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

3.  Bone marrow colony-forming unit assay in cats with naturally occurring myelodysplastic syndromes.

Authors:  Naho Nagashima; Masaharu Hisasue; Katsumi Higashi; Rui Kano; Hajime Tsujimoto; Atsuhiko Hasegawa
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

Review 4.  Pathogenic microRNA's in myeloid malignancies.

Authors:  Mona Khalaj; Montreh Tavakkoli; Alec W Stranahan; Christopher Y Park
Journal:  Front Genet       Date:  2014-11-19       Impact factor: 4.599

5.  Identification of genes underlying different methylation profiles in refractory anemia with excess blast and refractory cytopenia with multilineage dysplasia in myelodysplastic syndrome.

Authors:  Suee Lee; Hyuk-Chan Kwon; Sung-Hyun Kim; Sung Yong Oh; Ji Hyun Lee; Yeon-Su Lee; Daekwan Seo; Jin-Yeong Han; Hyo-Jin Kim
Journal:  Korean J Hematol       Date:  2012-09-25

6.  Programmed necroptosis is upregulated in low-grade myelodysplastic syndromes and may play a role in the pathogenesis.

Authors:  Jing Zou; Qiong Shi; Heidi Chen; Ridas Juskevicius; Sandra S Zinkel
Journal:  Exp Hematol       Date:  2021-09-24       Impact factor: 3.084

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.